Temasek Holdings Private Ltd Has $65.44 Million Stake in Danaher Corporation $DHR

Temasek Holdings Private Ltd lifted its holdings in shares of Danaher Corporation (NYSE:DHRFree Report) by 69.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 285,856 shares of the conglomerate’s stock after buying an additional 117,050 shares during the quarter. Temasek Holdings Private Ltd’s holdings in Danaher were worth $65,438,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher during the 4th quarter worth approximately $26,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher during the 4th quarter worth approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% during the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the 3rd quarter worth approximately $25,000. Finally, WFA of San Diego LLC acquired a new stake in shares of Danaher during the 2nd quarter worth approximately $26,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.5%

Danaher stock opened at $181.04 on Tuesday. The stock has a market capitalization of $128.13 billion, a PE ratio of 35.02, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a 50 day moving average of $180.73 and a 200-day moving average of $204.27.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.88 earnings per share. On average, equities research analysts anticipate that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.

Wall Street Analyst Weigh In

DHR has been the subject of several analyst reports. Wells Fargo & Company lowered their price target on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 22nd. TD Cowen decreased their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Barclays decreased their price objective on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Finally, Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $233.61.

Get Our Latest Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.